Biolevate raises €30M Series A led by RAISE France and Orange Ventures to scale life sciences AI platform for automating scientific and regulatory workflows.
Amount Raised
€30 Million
Round Type
Series A
ParisArtificial IntelligenceMachine LearningNatural Language ProcessingInvestors
Description
Biolevate, a Paris-based life sciences AI company founded by former Dataiku engineers, has raised €30 million in Series A funding to expand its enterprise agentic AI platform. The round was co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures. The platform automates scientific and regulatory workflows across drug discovery, clinical trials, and regulatory compliance while maintaining human oversight in regulated environments. Biolevate now serves over a dozen enterprise customers and has achieved a 16x acceleration in literature reviews and 80% efficiency gains in regulatory intelligence.
Quick answer
Biolevate raised €30 Million in a Series A round, dated September 22, 2026. Investors: EQT Ventures, MSD Global Health Innovation Fund, Station F, Raise France and Orange Ventures. Biolevate is based in Paris, Ile-de-France, France.
- How much did Biolevate raise?
- Biolevate raised €30 Million in a Series A round on September 22, 2026.
- Who invested in Biolevate?
- EQT Ventures, MSD Global Health Innovation Fund, Station F, Raise France and Orange Ventures are named as investors in this round.
- What does Biolevate do?
- Biolevate is a Paris-based company that assists medical writers in creating documentation for new drugs through its platform.
- Where is Biolevate based and how big is it?
- Biolevate is based in Paris, Ile-de-France, France. Fundz records about 17 employees.
- Who are the decision-makers at Biolevate?
- Fundz holds 2 contacts at Biolevate. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Natural Language Processing and Artificial Intelligence around the same time
Companies in the same sectors as Biolevate that raised within 45 days of this round, from Fundz verified event records.
- Guava AI Systems raised $13M (Seed) on November 6, 2026.
- Amity raised $100M (Series D) on November 4, 2026.
- Granter raised $1.8M (Seed) on November 3, 2026.
- Tallia raised $4.5M (Seed) on November 3, 2026.
- Lazarus AI raised $43M on November 3, 2026.
- SuperMe raised $20M on November 2, 2026.
Who to call at Biolevate, and when
A new round usually means Biolevate is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biolevate raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biolevate, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biolevate. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biolevate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBiolevate raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.